Pharmacerto SRL
2.6 FTEPharmacerto reported total assets of €2.34m at the end of the 2025 financial year (annual accounts filed with the NBB on 04 Mar 2026), with 2.6 full-time equivalents.
The score of Pharmacerto shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +39 % Total assets +31 % Headcount (avg FTE) +24 %
Accounts of the company itself (not consolidated).
The full file covers 11 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmacerto's annual accounts
Filed annual accounts
- Year ended 30 Sep 2025filed on 04 Mar 2026
- Year ended 30 Sep 2024filed on 29 Apr 2025
- Year ended 30 Sep 2023filed on 22 Mar 2024
- Year ended 30 Sep 2022filed on 30 Mar 2023
- Year ended 30 Sep 2021filed on 05 May 2022
Pharmacerto's financial analysis
- Solvency63.6%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmacerto
Pharmacerto's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0471.562.629
- VAT number
- BE0471562629
- Peppol
- Registered · 0208:0471562629 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 30 Mar 2000
- Registered office
- 9112 Sint-Niklaas
- Size
- Micro · 2.6 FTE
- Latest accounts
- 2025 · filed on 04 Mar 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharmacerto (SRL) has been based in Sint-Niklaas since 2000, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 195,955 € and equity of €1.49m; its revenue is not published. With 2.6 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 63.6%, above the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Pharmacerto
Companies in the same business, of comparable size and area, outside its group.
- Hoffmann Apotheek Retail sale of pharmaceutical products Keerbergen · balance sheet €2.34m
- Pharma Guillaume Retail sale of pharmaceutical products Ciney · balance sheet €2.35m
- Apotheek Leemans-Vanheusden Retail sale of pharmaceutical products Bilzen-Hoeselt · balance sheet €2.34m
- Kristof Beheyt Retail sale of pharmaceutical products Maldegem · balance sheet €2.34m
- Holsbeek Schilde Retail sale of pharmaceutical products Schilde · balance sheet €2.33m
- De Munter - De Waele Retail sale of pharmaceutical products Laarne · balance sheet €2.32m
- Pharmacie Voss-Richard Retail sale of pharmaceutical products Verlaine · balance sheet €2.38m
- Espidec Retail sale of pharmaceutical products Sint-Genesius-Rode · balance sheet €2.30m
Frequently asked questions about Pharmacerto
What is the revenue of Pharmacerto?
Pharmacerto files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharmacerto?
In Belgium, the VAT number is the company number prefixed with BE: BE0471562629 for Pharmacerto, if the company is VAT-registered. Its company number (CBE) is 0471.562.629.
Where is the registered office of Pharmacerto?
According to the CBE register, the registered office of Pharmacerto is in 9112 Sint-Niklaas.
What is the equity of Pharmacerto?
At the close of the 2025 financial year, the equity of Pharmacerto amounts to 1,489,890 €, a solvency of 63.6% of total assets.
How many people work at Pharmacerto?
2.6 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Pharmacerto?
The register lists 1 active mandates at Pharmacerto. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmacerto
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →